Minnesota legislation · 94th Legislature 2025-2026
Minnesota SF4189: Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases
Status: In committee, April 7, 2026
What the bill says
A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money.
From the introduced text, March 4, 2026:
A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money. Section 1. new text begin [ADDED: STUDY AND REPORT ON ACTIVITIES TO SUPPORT INNOVATIONS IN CELL AND GENE THERAPIES TO TREAT RARE DISEASES.] new text end new text begin [ADDED: Subdivision 1.] new text end new text begin [ADDED: Legislative intent.] new text end new text begin [ADDED: The legislature finds that the development of cell and gene therapies offers significant promise to treat and potentially cure a wide range of diseases, including cancer, rare genetic disorders, and autoimmune conditions. The legislature recognizes that the state of Minnesota is a national leader in biomedical research and health care innovation and recognizes the importance of fostering scientific progress and promoting economic development in cell and gene therapy.] new text end new text begin [ADDED: Subd. 2.] new text end new text begin [ADDED: State policy.] new text end new text begin [ADDED: It is the policy of the state of Minnesota to support and encourage the advancement, commercialization, and clinical translation of new technologies and applications in the fields of cell and gene therapy. These activities include but are not limited to research and development …
Sponsors
- Julia Coleman (R) · primary sponsor
- Liz Boldon (D)
- Jordan Rasmusson (R)
- Hemmingsen-Jaeger, Amanda H. (D, 47)
- Jeremy Miller (R)
Latest actions
- : Author added Miller
- : Author added Hemmingsen-Jaeger
- : Author added Rasmusson
- : Referred to Health and Human Services
- : Introduction and first reading
Common questions
- What is SF4189?
- SF4189 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases.
- What does SF4189 do?
- In its own words: A bill for an act relating to health; directing the commissioner of health to study and report on activities to support innovations in cell and gene therapy to treat rare diseases; requiring a report; appropriating money.
- What is the status of SF4189?
- In committee as of April 7, 2026. Latest action: Author added Miller (April 7, 2026).
- Who sponsored SF4189?
- Julia Coleman (R), with 4 co-sponsors.
- Where is the official record for SF4189?
- On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=SF4189&y=2025&ssn=0&b=senate
Source: official Minnesota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.